Value Investing
Value Investing Articles
In Thursday's trading, all the major airlines hit new 52-week highs following positive earnings reports from United Continental and Southwest Airlines.
Published:
Now that all four of the largest U.S. banks have reported fourth-quarter and full-year earnings, it seems like a good time to try to figure out what the banks' investors have to look forward to.
Published:
Here are the five large-cap oil stocks with Buy ratings currently at Jefferies. The theme is clear. Buy the big-boys that pay the big dividends.
Published:
The equity research team at Oppenheimer has released the firm's 35 best trading ideas for 2015, and we screened the list for large cap stocks that have declined substantially since the beginning of...
Published:
Last Updated:
A new report from Credit Suisse's Kulbinder Garcha maintains a strong Underperform rating in IBM shares. Why this report matters is that Garcha is perhaps the most bearish of all Wall Street analysts.
Published:
Here are six top MLPs to buy now for investors that can stand some volatility in a growth and income portfolio. All are rated Outperform at J.P. Morgan.
Published:
When two stocks run up over 50% and 30% on the same news, investors have to wonder if the move in the stock was justified or if the news-pop was due to trading factors and sentiment.
Published:
Merrill Lynch has upgraded Windstream Holdings and Frontier Communications to Buy ratings from Neutral.
Published:
After the Dow gained 7.5% and the S&P 500 was up 11.4% in 2014, 24/7 Wall St. wants to know what lies ahead for the Dow in 2015. Our methodology and track record for prior years is included.
Published:
Last Updated:
Cowen has a long list of stocks that are out of favor at many other firms on Wall Street. These five are leaders in their respective sectors and have big dividends.
Published:
As the nation's largest health insurance provider, UnitedHealth is often front and center in the fight or review of the Affordable Care Act.
Published:
One key consideration for the year ahead is that the Pfizer of 2016 or 2017 is likely to be night and day different from the Pfizer of 2005.
Published:
One key consideration for the year ahead is that Microsoft is in a very different place than it was a year ago, now that Satya Nadella is in firm control of the company.
Published:
One key consideration for the year ahead is that J.P. Morgan is now past its trading losses and charge-off scandals. Also, Jamie Dimon is now believed to be healthy and cancer-free.
Published:
A key consideration for the year ahead is that Travelers depends heavily on its investment income for its profits. The sooner that the Fed raises interest rates, the better it is for the company.
Published: